Modern approaches to drafting general and individual monographs on human blood products

Blood products were first represented in the State Pharmacopoeia of the USSR IX and X editions (1961 and 1968) by a single monograph "Gamma globulin for the prevention of measles". During the next 50 years there were no general monographs (GM) or individual monographs (IM) in the State Pharmacopoeia of the Russian Federation that laid down regulatory requirements for the quality of human blood products. In this regard, there came a need to develop GMs and IMs on human blood products taking into account modern approaches, specific features of a complex multi-level production technology and modern harmonized requirements for blood products, ensuring their quality, efficacy and safety in humans. The Order of the Ministry of Health of the Russian Federation "On the adoption of general monographs and individual monographs” No. 768 of 21.11.2014 brought into effect 32 GMs and IMs on blood products, including 11 GMs and 5 IMs that have been introduced into the national pharmacopoeial texts for the first time. The monographs were developed with due regard to modern pharmacopoeial methods of analysis that account for a high level of quality control of this type of products.

общая фармакопейная статья, фармакопейная статья, плазма для фракционирования, препараты крови человека, альбумины, иммуноглобулины, факторы свертывания крови, general monograph, individual monograph, plasma for fractionation, human blood products, albumin, immunoglobulins, coagulation factors

1. Cohn EJ. The history of plasma fractionation. In: Andrus EC, ed. Advances in Military Medicine 1948; 1: 364–443.

2. The Federal law 12.04.2010 № 61-FZ "On circulation of medicinal products". On amendments of 17.12.2014 № 429 in the Federal law Article 4 paragraph 2. Available from: http://marketpublishers.com (in Russian).

3. Report medicine pharmaceuticals biotechnology. Available from: http://marketpublishers.com.

4. Dashkova NG. Ensuring the safety of blood transfusions infectious. Vestnik sluzhby krovi Rossii 2006; (3): 12–6 (in Russian).

5. Zubkova NV. Biotechnological aspects of effective and safe processing of donor plasma: problems and prospects. Biopreparation (Biopharmaceuticals) 2014; 1(49): 4–10 (in Russian).

6. Fedorov NA, Ulov AA, Cherkasov EG, Zhiburt EB. Minipul-NAT screening donated blood for HIV, hepatitis B and C viruses. Blood Center of Ministry of Health of Russia, Moscow. Available from: http://www.transfusion.ru/doc/gepbc.htm (in Russian).

7. The State pharmacopoeia of USSR. 9th ed. M .: Medicine; 1961 (in Russian).

8. The State pharmacopoeia of USSR. 10th ed. M .: Medicine; 1968 (in Russian).

9. European Pharmacopoeia 8.5 ed. Available from: http//online.edqm.eu/entry.htm.

10. The United States Pharmacopoeia. (USP 38). 2015.

11. The register of registered medicines FGBI "NTsESMP" electronic resource (in Russian).

12. The Federal law 12.04.2010 № 61-FZ "On circulation of medicines". Collection of laws of the Russian Federation, 2010, № 16, st.1815. On approval of the general pharmacopoeia articles and articles from the pharmacopoeia of 21.11.2014 № 768. Appendices 1, 2 (in Russian).

13. WHO. Safe blood and blood products. Guidelines for the organization, maintenance and use of equipment blood cold chain. 2009. Available from: http://www.who.int/blood safety/ru (in Russian).